Copyright
©The Author(s) 2018.
World J Gastroenterol. Jan 7, 2018; 24(1): 69-75
Published online Jan 7, 2018. doi: 10.3748/wjg.v24.i1.69
Published online Jan 7, 2018. doi: 10.3748/wjg.v24.i1.69
Figure 1 Comparison of the survival period.
The median of survival period was 246.000 ± 36.056 (7-738) d in Group A and 180.000 ± 25.724 (7-999) d in Group B, showing no significant difference.
Figure 2 Metallic stent patency period.
The median patency period was 265.000 ± 26.779 (1-965) d; 252.000 ± 35.998 (1-618) d in Group A and 269.000 ± 47.885 (1-965) d in Group B, with no significant difference.
- Citation: Sakai Y, Iwai T, Shimura K, Gon K, Koizumi K, Ijima M, Chiba K, Nakatani S, Sugiyama H, Tsuyuguchi T, Kamisawa T, Maetani I, Kida M. Safety and efficacy of metallic stent for unresectable distal malignant biliary obstruction in elderly patients. World J Gastroenterol 2018; 24(1): 69-75
- URL: https://www.wjgnet.com/1007-9327/full/v24/i1/69.htm
- DOI: https://dx.doi.org/10.3748/wjg.v24.i1.69